{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:49:39Z","timestamp":1792802979548,"version":"4.5.0"},"reference-count":29,"publisher":"Touch Medical Media, Ltd.","issue":"2","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"This article is published under the Creative Commons Attribution Non-commercial License.","id":[{"id":"https:\/\/ror.org\/02ed4cj64","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"abstract":"<p>\n                    <bold>Background:<\/bold>\n                    The coronavirus disease 2019 (COVID-19) pandemic was associated with an increased incidence of mucormycosis globally. However, the clinical pattern, epidemiologic features and risk factors for adverse outcomes are not well established.\n                    <bold>Methods:<\/bold>\n                    We performed a retrospective analysis of the data from patients hospitalized with proven mucormycosis between April 2021 and August 2021. Patients were managed with a multi-disciplinary approach involving medical, surgical, and comorbidity treatment. The clinical presentation, management details, complications and outcomes, including mortality, were reviewed from clinical records.\n                    <bold>Results:<\/bold>\n                    The mean age of presentation was 53.7 (\u00b1 11.8) years, and 88 (84.6%) were men. Of the 104 cases with COVID-19-associated mucormycosis, 97 (93.27%) patients had diabetes, and 80.8% had a haemoglobin A1C (HbA1c) of \u22656.4% at diagnosis. Seventy percent of diabetes cases experienced steroid-induced hyperglycaemia during treatment. Even with appropriate treatment, 17 (16.35%) patients died. High HbA1c and creatinine levels, presence of chronic kidney disease (CKD), need for intensive care unit admission, and orbital evisceration were the risk factors associated with high mortality on multivariate logistic regression analysis. Cox regression analysis revealed that the overall mortality increased by a factor of 12% with each 1 percentage point increase in HbA1c \u22656.4% (hazard ratio 1.12; 95% confidence interval 0.95\u20131.31). The mortality risk was even higher when diabetes was associated with CKD (hazard ratio 1.82; 95% confidence interval 0.24\u201314.00).\n                    <bold>Conclusion:<\/bold>\n                    High HbA1c and creatinine levels, intensive care unit admission, CKD, and aggressive disease requiring orbital evisceration are the predictors of mortality in patients with COVID-19-associated mucormycosis. Patients with these risk factors should be managed more actively to reduce morbidity and mortality.\n                  <\/p>","DOI":"10.17925\/ee.2023.19.2.2","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T09:46:28Z","timestamp":1687340788000},"page":"2","source":"Crossref","is-referenced-by-count":4,"title":["Clinical Profile and Factors Associated with Adverse Outcomes in Coronavirus Disease 2019-associated Mucormycosis: A Single-centre Study"],"prefix":"10.17925","volume":"19","author":[{"given":"Krishna S","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of General Medicine, PSG Institute of Medical Sciences and Research Center, Coimbatore, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Alagesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of General Medicine, PSG Institute of Medical Sciences and Research Center, Coimbatore, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanya","family":"Jose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Community Medicine, Goa Medical College, Goa, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidambaram","family":"Yoganathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of General Medicine, PSG Institute of Medical Sciences and Research Center, Coimbatore, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rethinam","family":"Saravanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Oral & Maxilofacial Surgery, PSGSSH, Coimbatore, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnasamy","family":"Karthikeyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of ENT, PSG Institute of Medical Sciences and Research Center, Coimbatore, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karuppannasamy","family":"Divya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Opthalmology, PSG Institute of Medical Sciences and Research Center, Coimbatore, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Babu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Dental Surgery, PSG Institute of Medical Sciences and Research Center, Coimbatore, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Rajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of General Medicine, PSG Institute of Medical Sciences and Research Center, Coimbatore, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M","family":"Pappachan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Medicine & Endocrinology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Faculty of Science, Manchester Metropolitan University, Manchester, UK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7274","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Reid G, Lynch JP 3rd, Fishbein MC, Clark NM. Mucormycosis.\n                      Semin Respir Crit Care Med\n                      . 2020;41:99\u2013114. DOI: 10.1055\/s-0039-3401992","DOI":"10.1055\/s-0039-3401992"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis.\n                      Clin Infect Dis\n                      . 2012;54:S16\u201322. DOI: 10.1093\/cid\/cir865","DOI":"10.1093\/cid\/cir865"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis: Aan update.\n                      J Fungi (Basel\n                      ). 2020;6:265. DOI: 10.3390\/jof6040265","DOI":"10.3390\/jof6040265"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Farmakiotis D, Kontoyiannis DP. Mucormycoses.\n                      Infect Dis Clin North Am\n                      . 2016;30:143\u201363. DOI: 10.1016\/j.idc.2015.10.011","DOI":"10.1016\/j.idc.2015.10.011"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses?\n                      Clin Microbiol Infect\n                      . 2014;20:74\u201381. DOI: 10.1111\/1469-0691.12466","DOI":"10.1111\/1469-0691.12466"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: Aa systematic review and meta-analysis of case reports.\n                      Clin Microbiol Infect\n                      . 2019;25:26\u201334. DOI: 10.1016\/j.cmi.2018.07.011","DOI":"10.1016\/j.cmi.2018.07.011"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Shah NN, Khan Z, Ahad H, et al. Mucormycosis an added burden to COVID-19 patients: An in-depth systematic review.\n                      J Infect Public Health\n                      . 2022;15:1299\u2013314. DOI: 10.1016\/j.jiph.2022.10.011","DOI":"10.1016\/j.jiph.2022.10.011"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Rocha ICN, Hasan MM, Goyal S, et al. COVID-19 and mucormycosis syndemic: Ddouble health threat to a collapsing healthcare system in India.\n                      Trop Med Int Health\n                      . 2021;26:1016\u20138. DOI: 10.1111\/tmi.13641","DOI":"10.1111\/tmi.13641"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Muthu V, Agarwal R, Rudramurthy SM, et al. Multicenter case-control study of COVID-19-associated mucormycosis outbreak, Iindia.\n                      Emerg Infect Dis\n                      . 2023;29:8\u201319. DOI: 10.3201\/eid2901.220926","DOI":"10.3201\/eid2901.220926"},{"key":"ref10","unstructured":"Government of India Ministry of Health & Family Welfare. Clinical guidance for management of adult COVID-19 patients. Available at: www.mohfw.gov.in (Date last accessed: 7 January 2023)"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Skiada A, Lass-Floerl C, Klimko N, et al. Challenges in the diagnosis and treatment of mucormycosis.\n                      Med Mycol\n                      . 2018;56:93\u2013101. DOI: 10.1093\/mmy\/myx101","DOI":"10.1093\/mmy\/myx101"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression.\n                      Source Code Biol Med\n                      . 2008;3:1\u20138. DOI: 10.1186\/1751-0473-3-17","DOI":"10.1186\/1751-0473-3-17"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Morris TP, Jarvis CI, Cragg W, et al. Proposals on Kkaplan-Mmeier plots in medical research and a survey of stakeholder views: KMkmunicate.\n                      BMJ Open\n                      . 2019;9:e030215. DOI: 10.1136\/bmjopen-2019-030215","DOI":"10.1136\/bmjopen-2019-030215"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Honavar SG. Code mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19.\n                      Indian J Ophthalmol\n                      . 2021;69:1361\u20135. DOI: 10.4103\/ijo.IJO_1165_21","DOI":"10.4103\/ijo.IJO_1165_21"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Baral PK, Aziz MA, Islam MS. Comparative risk assessment of COVID-19 associated mucormycosis and aspergillosis: A systematic review.\n                      Health Sci Rep\n                      . 2022;5:e789. DOI: 10.1002\/hsr2.789","DOI":"10.1002\/hsr2.789"},{"key":"ref16","unstructured":"World Health Organization. WHO report on the global tobacco epidemic 2019: Offer help to quit tobacco use. Available at: www.who.int\/publications\/i\/item\/9789241516204 (Date last accessed: 22 May 2022)."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Auberger J, Lass-Fl\u00f6rl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E. Significant association of invasive aspergillosis with smoking and acute myeloid leukemia.\n                      Mycoses\n                      . 2011;112\u20137. DOI: 10.1007\/s12185-008-0184-2","DOI":"10.1007\/s12185-008-0184-2"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Singla N, Sharma N, Sharma N, et al. Clinical profile of patients admitted with mucormycosis during the COVID-19 pandemic in medicine emergency of a tertiary care hospital in North India.\n                      Cureus\n                      . 2022;14:e29219. DOI: 10.7759\/cureus.29219","DOI":"10.7759\/cureus.29219"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Patel A, Kaur H, Xess I, et al. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.\n                      Clin Microbiol Infect\n                      . 2020;26:944. DOI: 10.1016\/j.cmi.2019.11.021","DOI":"10.1016\/j.cmi.2019.11.021"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Jeong W, Keighley C, Wolfe R, et al. Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.\n                      Int J Antimicrob Agents\n                      . 2019;53:589\u201397. DOI: 10.1016\/j.ijantimicag.2019.01.002","DOI":"10.1016\/j.ijantimicag.2019.01.002"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Muthu V, Agarwal R, Dhooria S, et al. Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis.\n                      Clin Microbiol Infect\n                      . 2021;27:538\u201349. DOI: 10.1016\/j.cmi.2020.12.035","DOI":"10.1016\/j.cmi.2020.12.035"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Ostovan VR, Tabrizi R, Bazrafshan H, et al. Mortality-related risk factors for coronavirus disease (COVID-19) -associated mucormycosis: A systematic review and meta-analysis.\n                      Curr Fungal Infect Rep\n                      . 2022;16:143\u201353. DOI: 10.1007\/s12281-022-00440-2","DOI":"10.1007\/s12281-022-00440-2"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Watanabe A, So M, Mitaka H, et al. Clinical features and mortality of COVID-19-associated mucormycosis: A systematic review and meta-analysis.\n                      Mycopathologia\n                      . 2022;187:271\u201389. DOI: 10.1007\/s11046-022-00627-8","DOI":"10.1007\/s11046-022-00627-8"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with COVID-19.\n                      N Engl J Med\n                      . 2021;384:693\u2013704. DOI: 10.1056\/NEJMoa2021436","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Chakravarty J, Gupta MK, Tilak R, et al. COVID-19-associated mucormycosis: Aa clinico-epidemiological study.\n                      J Diabetes Complications\n                      . 2022;36:108284. DOI: 10.1016\/j.jdiacomp.2022.108284","DOI":"10.1016\/j.jdiacomp.2022.108284"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Zirpe K, Pote P, Deshmukh A, et al. A retrospective analysis of risk factors of COVID-19 associated mucormycosis and mortality predictors: A single-center study.\n                      Cureus\n                      . 2021;13:e18718. DOI: 10.7759\/cureus.18718","DOI":"10.7759\/cureus.18718"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Sahu M, Shah M, Mallela VR, et al. COVID-19 associated multisystemic mucormycosis from India: A multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.\n                      Infection\n                      . 2022;1\u201310. DOI: 10.1007\/s15010-022-01891-y","DOI":"10.1016\/j.ekir.2022.07.024"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Riad A, Shabaan AA, Issa J, et al. COVID-19-associated mucormycosis (CAM): Case-series and global analysis of mortality risk factors.\n                      J Fungi (Basel\n                      ). 2021;7:837. DOI: 10.3390\/jof7100837","DOI":"10.3390\/jof7100837"},{"key":"ref29","unstructured":"World Health Organization. Coronavirus disease (COVID-19) dashboard. Available at: https:\/\/covid19.who.int\/ (Date last accessed: 27 April 2023)."}],"container-title":["European Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/touchendocrinology.com\/diabetes\/journal-articles\/clinical-profile-and-factors-associated-with-adverse-outcomes-in-coronavirus-disease-2019-associated-mucormycosis-a-single-centre-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:59:27Z","timestamp":1764745167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.touchendocrinology.com\/diabetes\/journal-articles\/clinical-profile-and-factors-associated-with-adverse-outcomes-in-coronavirus-disease-2019-associated-mucormycosis-a-single-centre-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"alternative-id":["EE.2023.19.2.2"],"URL":"https:\/\/doi.org\/10.17925\/ee.2023.19.2.2","relation":{},"ISSN":["1758-3772"],"issn-type":[{"value":"1758-3772","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}